Directive (EU) 2026/2450 was published on October 30 to amend the European framework for protecting workers from exposure to carcinogens, mutagens, and reprotoxic substances.
The regulation introduces stricter preventive obligations that affect workplace risk assessments, personal protective equipment use, and daily work schedules across member states, Medscape reported.
The updated rules establish that occupational exposure limit values must rely on up-to-date scientific evidence and technical data. Regulators also evaluate socioeconomic impacts and feasibility factors when setting these limits. While the regulation introduces changes, current Spanish preventive obligations remain applicable until national transposition takes place.
Antineoplastic drugs account for the largest share of compounded hazardous medications at 52 percent, which includes cytotoxic agents. Immunosuppressants, hormones, antivirals, and monoclonal antibodies each represent approximately six percent of the hazardous medications used in hospital settings.
Risk Assessments in Hospitals
A 2023 official survey evaluated occupational exposure risk management in hospitals and revealed gaps in safety protocols. Fewer than half of hospitals, specifically 43.5 percent, had assessed exposure risks at all relevant workstations. Another 43.5 percent conducted assessments for only certain occupational groups.
Nursing staff who administer medications and nursing assistants who provide patient care face the highest exposure levels. An average hospital employs 453 nursing staff members who administer medications and 320 nursing assistants for patient care. In contrast, pharmacists and pharmacy technicians who prepare or handle these drugs average 29 workers per hospital.
Exposure risks extend beyond direct handlers throughout the medication supply chain. Regulations require risk assessments during receipt, storage, nonsterile preparation, dispensing, cleaning, and waste management. An article published in the Archives of Toxicology reported that exposure to antineoplastic agents causes genotoxic damage in healthcare workers, though data on workers outside the healthcare sector remain limited.
Workers Require Breaks and Suitable Areas When Using PPE
The new directive requires periodic breaks for workers using personal protective equipment. Staff using this gear are entitled to take breaks in areas free from exposure risks. The directive does not set a fixed duration or interval for these pauses, leaving the timing to individual risk assessments.
According to the Spanish Society of Hospital Pharmacy, this requirement carries clear organizational implications for units preparing hazardous medications. Facilities must incorporate breaks into work schedules and plan staff shifts to provide coverage. They must also provide suitable break areas and establish strict procedures for donning and removing equipment to prevent contamination.
Equipment must fit each individual properly and undergo regular maintenance, with technical and organizational control measures taking priority. Respiratory protective equipment requires particularly careful selection to match each professional and task.
Implementation Timeline
The regulatory framework sets specific deadlines for adoption across member states. The directive takes effect on November 19, 2026. Spain must transpose the rules into national law by November 20, 2028, at the latest.